AU1537292A
(en)
*
|
1991-04-16 |
1992-11-17 |
Nippon Shinyaku Co. Ltd. |
Method of manufacturing solid dispersion
|
US5567439A
(en)
*
|
1994-06-14 |
1996-10-22 |
Fuisz Technologies Ltd. |
Delivery of controlled-release systems(s)
|
DE19509805A1
(de)
*
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
|
DE19602206A1
(de)
*
|
1996-01-23 |
1997-07-24 |
Basf Ag |
Zubereitungen nichtsteroidaler Analgetika
|
US6139872A
(en)
*
|
1996-08-14 |
2000-10-31 |
Henkel Corporation |
Method of producing a vitamin product
|
DE19733505A1
(de)
|
1997-08-01 |
1999-02-04 |
Knoll Ag |
Schnell wirksames Analgeticum
|
EP1137403B1
(en)
|
1998-12-11 |
2009-03-11 |
Nostrum Pharmaceuticals, Inc. |
Sustained release tablet containing hydrocolloid and cellulose ether
|
DE19901040A1
(de)
*
|
1999-01-14 |
2000-07-20 |
Knoll Ag |
Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe
|
DE19933289A1
(de)
*
|
1999-07-15 |
2001-01-18 |
Basf Ag |
Verfahren zur Herstellung eines Granulats aus einer Schmelze
|
US6327354B1
(en)
*
|
1999-08-17 |
2001-12-04 |
Ameritech Corporation |
Methods, systems, and articles for providing a family telecommunication service
|
AU775360B2
(en)
*
|
1999-09-24 |
2004-07-29 |
Janssen Pharmaceutica N.V. |
Antiviral compositions
|
DE19945982A1
(de)
*
|
1999-09-24 |
2001-03-29 |
Knoll Ag |
Geschwindigkeitsbestimmte Partikel
|
US6264981B1
(en)
†
|
1999-10-27 |
2001-07-24 |
Anesta Corporation |
Oral transmucosal drug dosage using solid solution
|
US7364752B1
(en)
|
1999-11-12 |
2008-04-29 |
Abbott Laboratories |
Solid dispersion pharamaceutical formulations
|
ATE329579T1
(de)
*
|
1999-11-12 |
2006-07-15 |
Abbott Lab |
Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
|
DE10026698A1
(de)
*
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
|
US20050175687A1
(en)
*
|
2001-01-30 |
2005-08-11 |
Mcallister Stephen M. |
Pharmaceutical formulations
|
US7883721B2
(en)
|
2001-01-30 |
2011-02-08 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
GB0102342D0
(en)
|
2001-01-30 |
2001-03-14 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
US7842308B2
(en)
|
2001-01-30 |
2010-11-30 |
Smithkline Beecham Limited |
Pharmaceutical formulation
|
US20040015519A1
(en)
*
|
2001-10-15 |
2004-01-22 |
Yukitoshi Maeda |
Content delivery server and content delivery system having the same
|
US7050559B2
(en)
*
|
2001-12-21 |
2006-05-23 |
Bellsouth Intellectual Property Corporation |
Monitoring a call forwarded to a network-based voice mail system
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
CN1681479A
(zh)
*
|
2002-08-12 |
2005-10-12 |
辉瑞产品公司 |
半有序药物和聚合物的药物组合物
|
BRPI0407181A
(pt)
*
|
2003-02-03 |
2006-02-07 |
Novartis Ag |
Formulação farmacêutica
|
EP1638527B1
(en)
*
|
2003-06-27 |
2006-10-25 |
BIOPROGRESS S.p.A. |
Composite product obtainable by cogrinding of an active principle with a copolymer n-vinyl-2-pyrrolidone/vinyl-acetate
|
TW200526274A
(en)
|
2003-07-21 |
2005-08-16 |
Smithkline Beecham Plc |
Pharmaceutical formulations
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
BR122018068298B8
(pt)
*
|
2003-08-06 |
2021-07-27 |
Gruenenthal Gmbh |
processo para a produção de um comprimido seguro contra abuso termo-moldado por extrusão sem descoramento
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US8025899B2
(en)
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
US8377952B2
(en)
*
|
2003-08-28 |
2013-02-19 |
Abbott Laboratories |
Solid pharmaceutical dosage formulation
|
BRPI0417338A
(pt)
*
|
2003-12-04 |
2007-04-17 |
Pfizer Prod Inc |
formas de dosagem de azitromicina multiparticulada por processos a base de lìquido
|
WO2005053653A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
WO2005053639A2
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Controlled release multiparticulates formed with dissolution enhancers
|
WO2005053652A1
(en)
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
|
PT1691787E
(pt)
*
|
2003-12-04 |
2008-09-02 |
Pfizer Prod Inc |
Método de formação de multipartículas farmacêuticas
|
BRPI0417348A
(pt)
*
|
2003-12-04 |
2007-03-13 |
Pfizer Prod Inc |
processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
|
BRPI0416534A
(pt)
*
|
2003-12-04 |
2007-01-09 |
Pfizer Prod Inc |
composições multiparticuladas com estabilidade melhorada
|
TW201240679A
(en)
*
|
2004-03-12 |
2012-10-16 |
Capsugel Belgium Nv |
Pharmaceutical formulations
|
WO2005123052A1
(fr)
*
|
2004-06-18 |
2005-12-29 |
Jiangsu Hengrui Medicine Co., Ltd. |
Composition medicamenteuse contenant de l'ambroxol et de l'erdosteine ou de l'acetylcysteine
|
DE102004032049A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
DE102004032103A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
KR101086254B1
(ko)
*
|
2004-11-04 |
2011-11-24 |
에스케이케미칼주식회사 |
생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법
|
DE102005005449A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
EP1800667A1
(en)
|
2005-12-23 |
2007-06-27 |
Losan Pharma GmbH |
Rapidly solubilizing ibuprofen granulate
|
RU2403033C2
(ru)
*
|
2005-03-22 |
2010-11-10 |
Лозан Фарма Гмбх |
Солюбилизированный ибупрофен
|
JP5284101B2
(ja)
*
|
2005-11-09 |
2013-09-11 |
ノバルティス アーゲー |
一時可塑剤を用いる医薬組成物の製造法
|
ZA200806138B
(en)
*
|
2005-12-16 |
2009-11-25 |
Hanmi Pharm Ind Co Ltd |
Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
|
EP2112925A4
(en)
*
|
2006-11-15 |
2013-01-09 |
Abbott Lab |
SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
JP2011503048A
(ja)
|
2007-11-08 |
2011-01-27 |
グラクソ グループ リミテッド |
医薬製剤
|
KR20100134557A
(ko)
*
|
2008-01-11 |
2010-12-23 |
씨아이피엘에이 엘티디. |
고체 약제학적 투여 제형
|
US8383152B2
(en)
|
2008-01-25 |
2013-02-26 |
Gruenenthal Gmbh |
Pharmaceutical dosage form
|
HUE030803T2
(en)
|
2008-05-09 |
2017-06-28 |
Gruenenthal Gmbh |
Process for the preparation of an intermediate powder formulation and a final solid dosage form using a spraying step \ t
|
AU2009256572A1
(en)
*
|
2008-06-13 |
2009-12-17 |
Capsugel Belgium Nv |
Hydroxypropyl cellulose capsule shell
|
US8041893B1
(en)
|
2008-09-09 |
2011-10-18 |
Vignette Software Llc |
System and method for managing large filesystem-based caches
|
EP2373346B1
(en)
|
2008-09-10 |
2019-06-12 |
BioChemics, Inc. |
Ibuprofen for topical administration
|
BRPI0914192A2
(pt)
|
2008-09-22 |
2015-11-03 |
Biochemics Inc |
distribuição transdérmica de fármaco usando um osmólito e agente vasoativo
|
AR077420A1
(es)
|
2009-07-22 |
2011-08-24 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a la manipulacion para opiaceos sensibles a la oxidacion
|
EP2456427B1
(en)
|
2009-07-22 |
2015-03-04 |
Grünenthal GmbH |
Hot-melt extruded controlled release dosage form
|
EP2531176B1
(en)
*
|
2010-02-03 |
2016-09-07 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
JP5933553B2
(ja)
|
2010-09-02 |
2016-06-15 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
アニオン性ポリマーを含む不正使用抵抗性剤形
|
ES2486791T3
(es)
|
2010-09-02 |
2014-08-19 |
Grünenthal GmbH |
Forma de dosificación resistente a la manipulación que comprende una sal inorgánica
|
US11730709B2
(en)
|
2010-10-29 |
2023-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US9744132B2
(en)
|
2010-10-29 |
2017-08-29 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
US11224659B2
(en)
|
2010-10-29 |
2022-01-18 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
US11202831B2
(en)
|
2010-10-29 |
2021-12-21 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
US9308213B2
(en)
|
2010-10-29 |
2016-04-12 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
KR20140006879A
(ko)
|
2011-02-17 |
2014-01-16 |
에프. 호프만-라 로슈 아게 |
고온 용융 압출에 의해 활성 약학 성분을 과냉된 액체 상태로부터 제어되는 방식으로 결정화시키는 방법
|
RS56527B1
(sr)
|
2011-07-29 |
2018-02-28 |
Gruenenthal Gmbh |
Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
|
LT2736495T
(lt)
|
2011-07-29 |
2017-11-10 |
Grünenthal GmbH |
Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
|
CA2864949A1
(en)
|
2012-02-28 |
2013-09-06 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
EP2838512B1
(en)
|
2012-04-18 |
2018-08-22 |
Grünenthal GmbH |
Tamper resistant and dose-dumping resistant pharmaceutical dosage form
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
JP6466417B2
(ja)
|
2013-05-29 |
2019-02-06 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
二峰性放出プロファイルを有する改変防止(tamper−resistant)剤形
|
MX371432B
(es)
|
2013-05-29 |
2020-01-30 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
|
MX368846B
(es)
|
2013-07-12 |
2019-10-18 |
Gruenenthal Gmbh |
Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo.
|
EP3073994A1
(en)
|
2013-11-26 |
2016-10-05 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of cryo-milling
|
UY36046A
(es)
|
2014-03-26 |
2015-10-30 |
Millennium Pharm Inc |
Formulaciones farmacéuticas, procesos para la preparación y métodos de uso
|
EP3142646A1
(en)
|
2014-05-12 |
2017-03-22 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
AU2015266117A1
(en)
|
2014-05-26 |
2016-11-24 |
Grunenthal Gmbh |
Multiparticles safeguarded against ethanolic dose-dumping
|
GB201502077D0
(en)
*
|
2015-02-09 |
2015-03-25 |
Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd |
Improved hme technology
|
WO2016128235A1
(en)
|
2015-02-11 |
2016-08-18 |
Nestec S.A. |
Vitamin a composition
|
EA035434B1
(ru)
|
2015-04-24 |
2020-06-15 |
Грюненталь Гмбх |
Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями
|
JP2018526414A
(ja)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
|